B.J. Scheessele’s Post

https://lnkd.in/eFrpj8be In a powerful piece for The Wall Street Journal, Humacyte CEO, Dr. Laura Niklason shares a poignant narrative on the role of biotechnology in saving lives and limbs amidst the Ukrainian conflict. Biotech Against Brutality: Dr. Niklason aligns with Dr. Jeff Colyer’s view that our healthcare systems must evolve to address the complex injuries caused by modern munitions. She stresses the need to adapt our medical tools and develop new therapies. Innovation on the Frontlines: Humacyte’s pioneering work in bioengineering blood vessels is a testament to the potential of regenerative innovations. A Call to Action: Dr. Niklason’s efforts underscore the critical impact of every minute in surgical care. Her work is not just about healing—it’s about hope and preparedness for the future. Dr. Niklason’s article is a compelling call to embrace biotechnological advancements in the face of adversity. Read her full insights in the WSJ Opinion section and join the conversation. #Biotech #Humacyte #Ukraine #WSJ

Amidst the reverent observance of Muharram, let us delve into the world of microscopic wonders and breakthroughs. Lordsmark Micro Biotech sends heartfelt wishes for a profound and innovative Muharram. Embrace the power of science and compassion. #Muharram2023 #MicroscopicWonders #LordsmarkMicroBiotech

🎉It's the New Year, which means...a SUPER exciting announcement is right around the corner! The pipeline of potential treatments for #Duchenne #musculardystrophy has never been more promising, and we're thrilled to invite you to join our Research Grant Announcement on Thursday, January 25, 2024. Learn how your support is fueling transformative research and bringing us one step closer to life-changing breakthroughs: https://bit.ly/3tKELtS.

𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐂𝐡𝐚𝐫𝐚𝐜𝐭𝐞𝐫𝐢𝐬𝐞 𝐚𝐧 𝐀𝐧𝐭𝐢-𝐂𝐑𝐈𝐒𝐏𝐑 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐓𝐡𝐚𝐭 𝐏𝐮𝐥𝐥𝐬 𝐀𝐩𝐚𝐫𝐭 𝐚 𝐂𝐑𝐈𝐒𝐏𝐑-𝐂𝐚𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐱 Researchers in Canada and China report the characterisation of AcrIF25, an anti-CRISPR protein that inhibits the type I-F CRISPR-Cas system by dismantling the fully assembled effector complex. The team, led by Alan Davidson at University of Toronto, reports that AcrIF25 is the first example of a protein that disassembles a large and stable macromolecular complex without any external energy source, and presents it as a paradigm for macromolecular complex inhibitors with potential in biotech applications. The findings were published yesterday in Nature. https://lnkd.in/eAp5uSK6 #crisprmedicinenews #crisprmedicine #crispr #cas9 #geneediting

𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐂𝐡𝐚𝐫𝐚𝐜𝐭𝐞𝐫𝐢𝐬𝐞 𝐚𝐧 𝐀𝐧𝐭𝐢-𝐂𝐑𝐈𝐒𝐏𝐑 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐓𝐡𝐚𝐭 𝐏𝐮𝐥𝐥𝐬 𝐀𝐩𝐚𝐫𝐭 𝐚 𝐂𝐑𝐈𝐒𝐏𝐑-𝐂𝐚𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐱 Researchers in Canada and China report the characterisation of AcrIF25, an anti-CRISPR protein that inhibits the type I-F CRISPR-Cas system by dismantling the fully assembled effector complex. The team, led by Alan Davidson at University of Toronto, reports that AcrIF25 is the first example of a protein that disassembles a large and stable macromolecular complex without any external energy source, and presents it as a paradigm for macromolecular complex inhibitors with potential in biotech applications. The findings were published yesterday in Nature. https://lnkd.in/eAp5uSK6 #crisprmedicinenews #crisprmedicine #crispr #cas9 #geneediting

Dr. Hesham Yosef, our Chief Scientific Officer, is set to address the Medical Biodefense Conference in Munich, Germany, from October 22 to 25, 2023. During his presentation, Dr. Yosef will showcase the advanced capabilities of Microphoton x's single-cell analysis technology in identifying multidrug-resistant bacteria. His talk will highlight the technology's remarkable speed in conducting antibiotic- and phage-susceptibility testing. Microphoton x is at the forefront of addressing the rising concern surrounding antibiotic-resistant bacteria, contributing significantly to the development of phage diagnostic solution. This innovation is vital in tackling the spread of bacteria that pose a severe threat to millions of lives. #antimicrobialresistance #AMR #phage  

The International Scientific Programme Committee invites you to contribute to the programme by submitting an abstract for possible inclusion in the 14th International Donor Registry Conference and WMDA Meetings in 2024. Please visit https://lnkd.in/dksQuApq for more information and guidelines. #allpatientsanddonorsmatter #callforabstracts #callforabstract #poster  #posterpresentation #scientificconference #stemcelldonation #stemcelltransplant #donorrecruiment #hlatyping #stemcells #allogeneic #autologous #celltherapy #cellulartherapy #cellandgenetherapy #regenerativemedicine #clinicaltrials #manufacturing #supplychain #cryopreservation #donors #donorselection #regulatoryaffairs #conference #research #lifescience #lifesciences #startingmaterial #startingmaterials

Oxygen published an article authored by Dr. Tyler W. LeBaron et al, titled "The On/Off History of Hydrogen in Medicine: Will the Interest Persist This Time Around" Https://https://lnkd.in/gYSmcjUM For years, without our knowledge until recently, we have been deriving benefits from this unique medical gas through several different avenues. Follow to learn more about this tiny molecule! #h2 #hydrogen #molecularhydrogen #molecularhydrogeninstitute #mhi #h2research

An Approach to Reduce Mitochondrial Function in the Heart Promotes Regeneration In an interesting reversal of the usual goals in aged tissue, researchers here demonstrate an approach that reduces mitochondrial function in heart muscle to provoke replication of cardiomyocyte cells and consequent regeneration. Since this is achie... https://lnkd.in/eVna8Jq8 #BioTech #science

With Bio-Techne’s selection of over 100K primary antibodies at your fingertips, your research possibilities are endless! Our simple search ensures you find the ideal match for your scientific discoveries. https://bit.ly/43ELYI4 #validatedantibodies #scientificresearch #innovation #scientificbreakthroughs #antibodies